Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Obesity &Amp; Overweight
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup, Denmark